Peyvandi, F., Scully, M., Hovinga, J., Cataland, S., Knobl, P., Wu, H., . . . Investigators, T. (2016). Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Citación estilo ChicagoPeyvandi, F., et al. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. 2016.
Cita MLAPeyvandi, F., et al. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. 2016.
Precaución: Estas citas no son 100% exactas.